Editore: W. B. Saunders Company, Philadelphia, PA, 1979
Da: Nealsbooks, Menominee, MI, U.S.A.
Hardcover. Condizione: As New. No Jacket. Pages are clean and unmarked. Cover corners and edges are unmarred. Binding is tight.
Editore: W. B. Saunders Co., Philadelphia, London and Toronto, 1979
Prima edizione
Hardcover. Condizione: Very Good +. No Jacket. First Edition. Volume 63, Number 4 - July 1979 issue of the Medical Clinics of North America. Contains 13 articles on clinical neurology. Illustrated. Book.
Hardcover. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Editore: Saunders, PA, 1979
Da: Between the Covers-Rare Books, Inc. ABAA, Gloucester City, NJ, U.S.A.
Prima edizione
Hardcover. Condizione: Fine. First edition. Fine.
EUR 18,29
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Fine. Gebrochener Buchrücken / Seiten oder Softcover umgeknickt. This book summarizes the current research on the efficacy and safety of Ticlopidine as an agent for preventing stroke.
EUR 22,62
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Near Fine. No Jacket. 3rd. shelf wear on the boards. internally clean and soundly bound. near fine copy. [SK]. Our orders are shipped using tracked courier delivery services.
EUR 56,11
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Very Good. Hardcover (no jacket; printed boards). Very good condition. With 20 illustrations. A few minor scuffs to extremities of boards. Pages are sound and clear. TA. Used.
EUR 60,64
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 78,24
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 162 pages. 9.25x6.10x0.40 inches. In Stock.
Condizione: Used.
EUR 88,35
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used.
EUR 88,18
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used.
EUR 48,37
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 58,39
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 46,22
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer New York Nov 2011, 2011
ISBN 10: 1461383080 ISBN 13: 9781461383086
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 53,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease. 176 pp. Englisch.
Lingua: Inglese
Editore: Springer, Springer Nov 2011, 2011
ISBN 10: 1461383080 ISBN 13: 9781461383086
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 53,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 176 pp. Englisch.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.